Home / Import refusals / F23-9339962-1/30002/1

FDA Import Refusal F23-9339962-1/30002/1 — GlaxoSmithKline Manufacturing S.p.A.

GlaxoSmithKline Manufacturing S.p.A. — FEI 3002807114

The FDA refused shipment F23-9339962-1/30002/1 from GlaxoSmithKline Manufacturing S.p.A. (Italy) on September 3, 2025. The refused product falls under Drugs and Biologics — BELIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 3, 2025
Country
Italy
Product Category
Drugs and Biologics
Product Code
58MCY20 BELIMUMAB
Charges
75

Recent inspections

  • 1244033 (VAI Thu Oct 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064045 (VAI Fri Sep 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 982333 (NAI Fri Jul 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 934049 (VAI Wed May 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 842545 (NAI Wed Jul 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • F23-9340393-6/30002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • F23-9340393-6/30002/2 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • F23-9339962-1/30002/2 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7048370-3/11/1 (Wed Apr 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • UPS-8713880-8/1/1 (Wed Feb 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources